関連する実験動画
Updated: Sep 10, 2025
07:08
Burn Injury-Induced Pain and Depression-Like Behavior in Mice
Published on: September 29, 2021
3.2K
灼熱 患者 の ため の 抗 ムスカリン 薬: 感覚 の 回復 に 役立つ か 害 を 及ぼす か
Zachary H Zamore1, Jeffrey Khong1, Rachana Suresh1
1Department of Plastic and Reconstructive Surgery, Johns Hopkins University School of Medicine, Baltimore, USA.
Burns : journal of the International Society for Burn Injuries
|August 20, 2025
まとめ
火傷患者の抗ムスカリン薬の使用は,神経再生の潜在的指標であるパレステシアの発症の可能性が高いと関連していました. この感覚の変化の機能的影響を評価するためにさらなる研究が必要である.
科学分野:
- 灼傷に関する研究
- 外周神経の再生
- 薬理学的介入
背景:
- 火傷はしばしば神経損傷を引き起こし,痛み,麻痺,保護感覚の喪失を引き起こします.
- 火傷後の神経再生は 患者の回復とさらなる傷害を防ぐために不可欠です
- 膀の過剰活動に対して一般的に使用される抗ムスカリンの薬は,神経の成長を支えるのに有望である.
研究 の 目的:
- 火傷時の抗ムスカリン薬の使用と,その後の神経再生との関連を調査する.
- 燃焼後の感覚の変化の可能性に抗ムスカリンの治療が影響するかどうかを判断する.
主な方法:
- トリネットX研究データベースの遡及分析
- ICD-10-CMコードを用いて火傷患者の特定
- 抗ムスカリンの薬物使用者と,傾向スコアが一致した対照群の比較.
- 神経再生のプロキシとして,負傷後3〜24ヶ月間のパレステシアの発生.
主要な成果:
- 燃焼コード法 (解剖学的領域またはTBSA) にかかわらず,対照群と比較して,アンチムスカリニクスの使用者はパレスチアを発症する可能性が2倍以上でした.
- 抗ムスカリンの使用量も増加した.
- 統計的有意性は両方のコホートで維持された (p < 0. 001).
結論:
- 抗ムスカリンの治療を受けた火傷患者では,神経再生の可能性を示唆するパレステシアの発生率が高かった.
- パレステシアは感覚の回復を示しますが 生活の質に影響を与える異常または痛ましい感覚としても表れます
- これらの感覚の変化の機能的結果と臨床的意義を確かめるには,さらなる研究が不可欠です.
関連する概念動画
01:26Cholinergic Antagonists: Therapeutic Uses
871
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
871
01:28Cholinergic Antagonists: Pharmacological Actions
1.2K
Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
1.2K
01:24Cholinergic Antagonists: Pharmacokinetics
560
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
560
01:20Antiasthma Drugs: Muscarinic Receptor Antagonists
452
Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
452
01:22Burn Injuries
2.8K
Burn injuries occur when the skin and underlying tissues are damaged due to exposure to heat, electricity, chemicals, radiation, or friction. They can vary in severity, from minor superficial burns to severe deep burns that can be life-threatening.
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
2.8K
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
828
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
828